Statins, mood, sleep, and physical function: A systematic review

European Journal of Clinical Pharmacology

Volumn 70, Issue 12, 2014, Pages 1413-1422

  Swiger, Kristopher J ^a   Manalac, Raoul J ^a   Blaha, Michael J ^a   Blumenthal, Roger S ^a   Martin, Seth S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Energy; Mood; Physical function; Sleep; Statin therapy

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

BIPOLAR DISORDER; COCHRANE LIBRARY; EMBASE; HUMAN; MAJOR DEPRESSION; MEDLINE; MOOD; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA; SLEEP; SYSTEMATIC REVIEW; AFFECT; DRUG EFFECTS; EXERCISE; MOTOR ACTIVITY; QUALITY OF LIFE; STATISTICAL BIAS;

AFFECT; BIAS (EPIDEMIOLOGY); HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MOTOR ACTIVITY; PHYSICAL EXERTION; QUALITY OF LIFE; SLEEP;

EID: 84922092852     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-014-1758-y     Document Type: Review

References (54)

1. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW (2014) 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl 2):S1-S45. doi:10.1161/01.cir.0000437738.63853.7a
2. Swiger KJ, Manalac RJ, Blumenthal RS, Blaha MJ, Martin SS (2013) Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects. Mayo Clin Proc 88:1213-1221. doi:10.1016/j.mayocp.2013.07.013
3. Richardson K, Schoen M, French B, Umscheid CA, Mitchell MD, Arnold SE, Heidenreich PA, Rader DJ, deGoma EM (2013) Statins and cognitive function: a systematic review. Ann Intern Med 159: 688-697. doi:10.7326/0003-4819-159-10-201311190-00007
4. Muldoon MF, Rossouw JE, Manuck SB, Glueck CJ, Kaplan JR, Kaufmann PG (1993) Low or lowered cholesterol and risk of death from suicide and trauma. Metabolism 42:45-56
5. You H, Lu W, Zhao S, Hu Z, Zhang J (2013) The relationship between statins and depression: a review of the literature. Expert Opin Pharmacother 14:1467-1476. doi:10.1517/14656566.2013.803067
6. O'Neil A, Sanna L, Redlich C, Sanderson K, Jacka F, Williams LJ, Pasco JA, Berk M (2012) The impact of statins on psychological wellbeing: a systematic review and meta-analysis. BMC Med 10: 154. doi:10.1186/1741-7015-10-154
7. While A, Keen L (2012) The effects of statins on mood: a review of the literature. Eur J Cardiovasc Nurs 11:85-96. doi:10.1016/j.ejcnurse.2010.08.008
8. Vgontzas AN, Kales A, Bixler EO, Manfredi RL, Tyson KL (1991) Effects of lovastatin and pravastatin on sleep efficiency and sleep stages. Clin Pharmacol Ther 50:730-737
9. Golomb BA, Evans MA, Dimsdale JE, White HL (2012) Effects of statins on energy and fatiguewith exertion: results froma randomized controlled trial. Arch Intern Med 172:1180-1182. doi:10.1001/archinternmed.2012.2171
10. Mikus CR, Boyle LJ, Borengasser SJ, Oberlin DJ, Naples SP, Fletcher J, Meers GM, Ruebel M, Laughlin MH, Dellsperger KC, Fadel PJ, Thyfault JP (2013) Simvastatin impairs exercise training adaptation. J Am Coll Cardiol 62:709-714. doi:10.1016/j.jacc.2013.02.074
11. The IMS Institute for Healthcare Informatics (2012) The use of medicines in the United States: Review of 2011. http://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII-Medicines-in-U.S-Report-2011.pdf. Accessed 14 July 2014
12. Martin SS, Metkus TS, Horne A, Blaha MJ, Hasan R, Campbell CY, Yousuf O, Joshi P, Kaul S, Miller M, Michos ED, Jones SR, Gluckman TJ, Cannon CP, Sperling LS, Blumenthal RS (2012) Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendations. Am J Cardiol 110:307-313. doi:10.1016/j.amjcard.2012.03.023
13. JUPITER Study Group, Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195-2207. doi:10.1056/NEJMoa0807646
14. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR, Hedges Team (2005) Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ 330:1179
15. Higgins J (2008) Chapter 8: Assessing risk of bias in included studies: Table 8.5 a. Cochrane Handbook for Systematic Reviews. http://hiv.cochrane.org/sites/hiv.cochrane.org/files/uploads/Ch08-Bias.pdf. Accessed 14 July 2014
16. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed 14 July 2014
17. Boumendil E, Tubert-Bitter P (1995) Depression-induced absenteeismin relation to antihyperlipidemic treatment: a study using GAZEL cohort data. Epidemiology 6:322-325
18. Agostini JV, Tinetti ME, Han L, McAvay G, Foody JM, Concato J (2007) Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc 55:420-425
19. Feng L, Yap KB, Kua EH, Ng TP (2010) Statin use and depressive symptoms in a prospective study of community-living older persons. Pharmacoepidemiol Drug Saf 19:942-948. doi:10.1002/pds.1993
20. Smeeth L, Douglas I, Hall AJ, Hubbard R, Evans S (2009) Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol 67:99-109. doi:10.1111/j.1365-2125.2008.03308.x
21. Hoogwegt MT, Theuns DA, Kupper N, Jordaens L, Pedersen SS (2013) Relation of statin therapy to psychological functioning in patients with an implantable cardioverter defibrillator. Am J Cardiol 111:1169-1174. doi:10.1016/j.amjcard.2012.12.047
22. Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM (2003) Long-term statin use and psychological well-being. J Am Coll Cardiol 42:690-697
23. Mansi I, Frei CR, Pugh MJ, Mortensen EM (2013) Psychologic disorders and statin use: a propensity score-matched analysis. Pharmacotherapy 33:615-626. doi:10.1002/phar.1272
24. Yang C-C, Jick SS, Jick H (2003) Lipid-lowering drugs and the risk of depression and suicidal behavior. Arch Intern Med 163:1926-1932
25. Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M (2010) Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom 79: 323-325. doi:10.1159/000319530
26. Stafford L, Berk M (2011) The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J Clin Psychiatry 72:1229-1235. doi:10.4088/JCP.09m05825blu
27. Harrison RW, Ashton CH (1994) Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers. Br J Clin Pharmacol 37:231-236
28. Carlsson CM, Papcke-Benson K, Carnes M, McBride PE, Stein JH (2002) Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults. Drugs Aging 19:793-805
29. Ormiston T, Wolkowitz OM, Reus VI, Manfredi F (2003) Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics 44:412-414
30. HyyppäMT, Kronholm E, Virtanen A, Leino A, Jula A (2003) Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial. Psychoneuroendocrinology 28:181-194
31. Muldoon MF, Barger SD, Ryan CM, Flory JD, Lehoczky JP, Matthews KA, Manuck SB (2000) Effects of lovastatin on cognitive function and psychological well-being. Am J Med 108:538-546
32. Morales K, Wittink M, Datto C, DiFilippo S, Cary M, TenHave T, Katz IR (2006) Simvastatin causes changes in affective processes in elderly volunteers. J Am Geriatr Soc 54:70-76
33. Ghanizadeh A, Hedayati A (2013) Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial. Depress Anxiety 30:1084-1088. doi:10.1002/da.22195
34. Downs JR, Oster G, Santanello NC (1993) HMG CoA reductase inhibitors and quality of life. JAMA 269:3107-3108
35. Wardle J, Armitage J, Collins R, Wallendszus K, Keech A, Lawson A (1996) Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group. BMJ 313:75-78
36. Stewart R, Sharples K (2000) Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. Arch Int Med 160:3144-3152
37. Hsia J, MacFadyen JG, Monyak J, Ridker PM (2011) Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). J Am Coll Cardiol 57: 1666-1675. doi:10.1016/j.jacc.2010.09.082
38. Schaefer E (1988) HMG-CoA reductase inhibitors for hypercholesterolemia. N Engl J Med 319:1222-1223
39. Tobert JA (1988) Efficacy and long-term adverse effect pattern of lovastatin. Am J Cardiol 62:28J-34J
40. Black DM, Lamkin G, Olivera EH, Laskarzewski PM, Stein EA (1990) Sleep disturbance and HMG CoA reductase inhibitors. JAMA 264:1105
41. Ditschuneit HH, Kuhn K, Ditschuneit H (1991) Comparison of different HMG-CoA reductase inhibitors. Eur J Clin Pharmacol 40(Suppl 1):S27-S32
42. Barth JD, Kruisbrink OA, Van Dijk AL (1990) Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia. BMJ 301:669
43. Eckernäs SA, Roos BE, Kvidal P, Eriksson LO, Block GA, Neafus RP, Haigh JR (1993) The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia. Br J Clin Pharmacol 35:284-289
44. Giri J, McDermott MM, Greenland P, Guralnik JM, Criqui MH, Liu K, Ferrucci L, Green D, Schneider JR, Tian L (2006) Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol 47:998-1004
45. Mondillo S, Ballo P, Barbati R, Guerrini F, Ammaturo T, Agricola E, Pastore M, Borrello F, Belcastro M, Picchi A, Nami R (2003) Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med 114:359-364
46. Gray SL, Aragaki AK, LaMonte MJ, Cochrane BB, Kooperberg C, Robinson JG, Woods NF, LaCroix AZ (2012) Statins, angiotensin-converting enzyme inhibitors, and physical performance in older women. J Am Geriatr Soc 60:2206-2214. doi:10.1111/jgs.12029
47. MedlinePlus (2014) Simvastatin. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a692030.html. Accessed 14 July 2014
48. National Institute of Mental Health (2014) Major Depressive Disorder Among Adults http://www.nimh.nih.gov/statistics/1MDD-ADULT.shtml. Accessed 14 July 2014
49. Roth T (2007) Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med 3:S7-S10
50. Botti RE, Triscari J, Pan HY, Zayat J (1991) Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects. Clin Neuropharmacol 14:256-261
51. Locatelli S, Lütjohann D, Schmidt HH, Otto C, Beisiegel U, von Bergmann K (2002) Reduction of plasma 24 S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Arch Neurol 59:213-216
52. Reuters (2012) Do statins drain your energy? http://www.foxnews.com/health/2012/06/12/do-statins-drain-your-energy/. Accessed 14 July 2014
53. Golomb BA, Criqui MH, White H, Dimsdale JE (2004) Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry. Arch Intern Med 164:153-162
54. Perez AC, Jhund P, Preiss D, Kjekshus J, McMurray JJ (2013) Effect of rosuvastatin on fatigue in patients with heart failure. J Am Coll Cardiol 61:1121-1122. doi:10.1016/j.jacc.2012.12.004